| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | 7I279E1NZ8 |
| InChI Key | OAVGBZOFDPFGPJ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H22N6O2 |
| Molecular Weight | 438.49 |
| AlogP | 2.43 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 94.22 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Protein kinase C (PKC) inhibitor | PubMed |
| Primary Target | |
|---|---|
| protein kinase C alpha | |
| protein kinase C beta | |
| protein kinase C delta | |
| protein kinase C epsilon | |
| protein kinase C eta | |
| protein kinase C theta |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
| Uveitis, Posterior | 2 | D015866 | ClinicalTrials |
| Psoriasis | 2 | D011565 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 425637-18-9 |
| ChEBI | 90531 |
| ChEMBL | CHEMBL565612 |
| DrugBank | DB12369 |
| FDA SRS | 7I279E1NZ8 |
| Guide to Pharmacology | 7946 |
| PDB | LW4 |
| PubChem | 10296883 |
| SureChEMBL | SCHEMBL2500835 |
| ZINC | ZINC000003973984 |